Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer

NCT03526432 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

110

Enrollment

OTHER

Sponsor class

Conditions

Endometrial Cancer

Interventions

DRUG: Bevacizumab
DRUG: Atezolizumab

Sponsor

University of Oklahoma

Collaborators

[object Object]